We are pleased to share the latest Middle East and Africa pharmaceutical market report covering Middle East, North Africa, French West Africa and South Africa for the period of MAT Q1 2015 to MAT Q1 2019. Along with a summary of the region, you will also find a detailed view for several Middle East and African countries where IQVIA has been collecting data for years.
The Middle East and Africa pharmaceutical market has remained steady at $25.6 B in value driven by growth in Institutional channel across multiple key markets; Both value and volumes grew at 9% from MAT Q1 2018 to MAT Q1 2019. KSA, Egypt and South Africa continue to drive Institutional sales growth at double digits; sales for Kuwait and Jordan declined by 4% and 6% respectively. Top 10 companies include mostly MNCs, however many local players have shown high growth.